HRP950459A2 - Spirostanyl glycosidal crystals - Google Patents

Spirostanyl glycosidal crystals Download PDF

Info

Publication number
HRP950459A2
HRP950459A2 HR08/298,106A HRP950459A HRP950459A2 HR P950459 A2 HRP950459 A2 HR P950459A2 HR P950459 A HRP950459 A HR P950459A HR P950459 A2 HRP950459 A2 HR P950459A2
Authority
HR
Croatia
Prior art keywords
crystalline
oxy
cellobiosyl
spirostan
fluorophenylcarbamoyl
Prior art date
Application number
HR08/298,106A
Other languages
English (en)
Croatian (hr)
Inventor
Allen J Douglas
Richard A Buzon
Michael P Dennino
Harry A Watson
Jonathan B Zung
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HRP950459A2 publication Critical patent/HRP950459A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR08/298,106A 1994-08-30 1995-08-25 Spirostanyl glycosidal crystals HRP950459A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29810694A 1994-08-30 1994-08-30

Publications (1)

Publication Number Publication Date
HRP950459A2 true HRP950459A2 (en) 1997-08-31

Family

ID=23149057

Family Applications (1)

Application Number Title Priority Date Filing Date
HR08/298,106A HRP950459A2 (en) 1994-08-30 1995-08-25 Spirostanyl glycosidal crystals

Country Status (20)

Country Link
US (1) US5804562A (fr)
EP (1) EP0778846A1 (fr)
JP (1) JPH09510735A (fr)
KR (1) KR970705574A (fr)
AU (1) AU2265395A (fr)
BR (1) BR9503827A (fr)
CA (1) CA2198097A1 (fr)
CO (1) CO4480032A1 (fr)
FI (1) FI970828L (fr)
HR (1) HRP950459A2 (fr)
IL (1) IL115062A0 (fr)
MA (1) MA23651A1 (fr)
MX (1) MX9701525A (fr)
NO (1) NO970910D0 (fr)
OA (1) OA10402A (fr)
PE (1) PE47696A1 (fr)
PL (1) PL318937A1 (fr)
SI (1) SI9520092A (fr)
TR (1) TR199501065A2 (fr)
WO (1) WO1996006854A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL195897B1 (pl) * 1998-03-26 2007-11-30 Phytopharm Plc Zastosowanie smilageniny
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629295A (en) * 1992-06-26 1997-05-13 Pfizer Inc. Steroidal glycosides for treating hypercholesterolemia
US5698526A (en) * 1993-12-28 1997-12-16 Pfizer Inc. Steroidal glycosides

Also Published As

Publication number Publication date
OA10402A (en) 2001-12-05
NO970910L (no) 1997-02-27
US5804562A (en) 1998-09-08
SI9520092A (en) 1997-12-31
CA2198097A1 (fr) 1996-03-07
KR970705574A (ko) 1997-10-09
FI970828A7 (fi) 1997-02-27
MA23651A1 (fr) 1996-04-01
AU2265395A (en) 1996-03-22
CO4480032A1 (es) 1997-07-09
TR199501065A2 (tr) 1996-06-21
FI970828A0 (fi) 1997-02-27
JPH09510735A (ja) 1997-10-28
BR9503827A (pt) 1996-09-10
IL115062A0 (en) 1995-12-08
FI970828L (fi) 1997-02-27
PE47696A1 (es) 1996-11-12
EP0778846A1 (fr) 1997-06-18
MX9701525A (es) 1997-05-31
WO1996006854A1 (fr) 1996-03-07
PL318937A1 (en) 1997-07-21
NO970910D0 (no) 1997-02-27

Similar Documents

Publication Publication Date Title
US5583239A (en) Antimicrobial sterol conjugates
SK158394A3 (en) Steroidal glycosides
PL123822B1 (en) Process for preparing novel tripeptideamides
HU221584B (hu) Új vastagbél- (colon) vagy csípőbél- (ileum) specifikus, cukortartalmú szteroidszármazékok, ezeket tartalmazó gyógyszerkészítmények és előállításuk
JP4613366B2 (ja) 抗炎症活性を有するマクロライドコンジュゲート
HRP950459A2 (en) Spirostanyl glycosidal crystals
JP2008504284A (ja) 新生糖ランダム化及びジギトキシン類似体
AP518A (en) Spirostanyl glycosidal crystalline monohydrate.
HUT76333A (en) Triterpene derivative and medicinal composition
CA1113006A (fr) Medicament agissant comme inhibiteur de la prostaglandine-synthetase
HRP941012A2 (en) Steroidal glycosides
US6150336A (en) Steroidal glycosides
CA2171740C (fr) Derives de 1,3,5(10)-estratriene, actifs par voie orale
US4265886A (en) Spiroketalins and their applications
JPH07233190A (ja) 骨吸収抑制・骨形成促進化合物
DE4330237C2 (de) 1-Methylsubstituierte Androsta-1,4-dien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
IL43287A (en) Fusidic acid conjugates their preparation and pharmaceutical compositions containing them
JP2000191685A (ja) コレスタノール化合物及びこれを含有する医薬
JPH1160592A (ja) コレスタノール化合物及びこれを含有する医薬
GB2024624A (en) Anti inflammatory spiroketalins
JPS6363698A (ja) 胆汁酸誘導体およびその塩ならびにその製造法
CN1156458A (zh) 螺甾烷基糖苷晶体
JPH02138292A (ja) ２’‐メチリデンピリミジンヌクレオシド化合物およびその医薬用途
JPH08104638A (ja) Ｉｌ−５産生抑制剤

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
OBST Application withdrawn